Critical Reviews in Microbiology

Papers
(The H4-Index of Critical Reviews in Microbiology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids154
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases81
TREM-2: friend or foe in infectious diseases?64
Salmonella in eggs and egg-laying chickens: pathways to effective control56
Dynamics of antibiotic resistance genes in plasmids and bacteriophages50
Current and emerging therapies for fungal biofilms and systemic infections48
Paving the way forward: Escherichia coli bacteriophages in a One Health approach47
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens46
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases45
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies43
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections40
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication35
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings32
Elucidating the multifaceted antibacterial mechanisms of luteolin: insights, challenges, and prospects for clinical translation32
LysR-type transcriptional regulators: state of the art30
Under the lens: using Raman spectroscopy as a unique system in biofilm analyses29
Exploring halophilic environments as a source of new antibiotics28
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review26
Anti- Candida albicans natural products: convergent technologies revolutionizing discovery from bioactivity assessment to targeted mechanisms26
Helicobacter pylori ’s secret resilience: coccoid forms, yeast havens, and outer membrane vesicle release for survival and spread25
Vibrio cholerae virulence and its suppression through the quorum-sensing system25
Helicobacter pylori eradication: developing antibiotic-independent antimicrobial moieties24
Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria24
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma24
0.12553691864014